I notice the filing content provided is primarily the cover page, table of contents, glossary, and forward-looking statements boilerplate of Dolby Laboratories' 10-K for fiscal year ended September 25, 2026. The substantive financial disclosure content (MD&A, financial statements, business description body text, etc.) was not included in the extracted text. However, the cover page alone contains several verifiable facts that exceed 150 words of substantive disclosure content (share counts, market cap figure, fiscal year end date, exchange listing, incorporation details).

Dolby Laboratories, Inc. filed its Annual Report on Form 10-K for the fiscal year ended September 25, 2026, with the U.S. Securities and Exchange Commission on November 17, 2026, disclosing share counts, market capitalization details, and corporate information as of the filing date.

Key Highlights

  • Fiscal year end: The annual report covers the fiscal year ended September 25, 2026.
  • Class A shares outstanding: As of October 23, 2026, the registrant had 58,771,115 shares of Class A common stock, par value $0.001 per share, outstanding.
  • Class B shares outstanding: As of October 23, 2026, the registrant had 33,951,901 shares of Class B common stock, par value $0.001 per share, outstanding.
  • Non-affiliate market value: The aggregate market value of voting common equity held by non-affiliates as of March 27, 2026 was $2.4 billion, according to the filing.
  • Exchange listing: Class A common stock is listed on NYSE:DLB; Class B common stock is registered pursuant to Section 12(g) of the Act and is not exchange-listed.
  • Large accelerated filer: The registrant indicated it qualifies as a large accelerated filer under Rule 12b-2 of the Exchange Act.

Dolby Laboratories Fiscal Year 2026 Annual Report: Filing Details and Share Structure

Dolby Laboratories, Inc. (NYSE:DLB), a Delaware corporation headquartered at 1275 Market Street, San Francisco, California 94103-1410, submitted its Form 10-K for the fiscal year ended September 25, 2026. The filing was made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, under Commission File Number 001-32431, according to the document.

The registrant disclosed that as of October 23, 2026, it had 58,771,115 shares of Class A common stock and 33,951,901 shares of Class B common stock outstanding, for a combined total of 92,723,016 shares across both classes. The filing states that the aggregate market value of voting common equity held by non-affiliates as of March 27, 2026 was $2.4 billion, with the calculation excluding shares held by executive officers, directors, and stockholders whose combined ownership of Class A and Class B common stock exceeds 5% of Class A shares outstanding as of that date. The filing notes this calculation "does not reflect a determination that such persons are affiliates for any other purposes."

The company confirmed it has filed all reports required under Section 13 or 15(d) during the preceding 12 months and has been subject to filing requirements for the past 90 days. The registrant also indicated it has submitted all required Interactive Data Files electronically. Portions of the company's Definitive Proxy Statement, to be filed in connection with the 2027 Annual Meeting of Stockholders, are incorporated by reference into Part III of the Form 10-K, and the company stated that proxy statement will be filed no later than 120 days after the conclusion of the fiscal year ended September 25, 2026. The filing contains forward-looking statements that, according to the company's own cautionary language, are "subject to risks and uncertainties" and that "actual results may differ materially" from those discussed.

What Was Disclosed

Dolby Laboratories filed a Form 10-K for fiscal year ended September 25, 2026, disclosing 58,771,115 Class A and 33,951,901 Class B shares outstanding as of October 23, 2026, a $2.4 billion non-affiliate market value as of March 27, 2026, and large accelerated filer status.